These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 23036578)
1. Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70. Froehner M; Koch R; Wirth MP Eur Urol; 2013 Jan; 63(1):e9. PubMed ID: 23036578 [No Abstract] [Full Text] [Related]
2. Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70. Mayr R; May M; Fritsche HM Eur Urol; 2013 Jan; 63(1):e10. PubMed ID: 23079054 [No Abstract] [Full Text] [Related]
3. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Mayr R; May M; Martini T; Lodde M; Comploj E; Pycha A; Strobel J; Denzinger S; Otto W; Wieland W; Burger M; Fritsche HM Eur Urol; 2012 Oct; 62(4):662-70. PubMed ID: 22534059 [TBL] [Abstract][Full Text] [Related]
4. Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy: BJU Int 2012;110(6 Pt B):E222-7 [Epub 2012 Feb 7]. Kamat AM Urol Oncol; 2013 Jul; 31(5):718-9. PubMed ID: 23796203 [TBL] [Abstract][Full Text] [Related]
5. Re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163. Novotny V; Wirth MP; Froehner M Eur Urol; 2014 Jul; 66(1):e13. PubMed ID: 24602933 [No Abstract] [Full Text] [Related]
6. Reply to Vladimir Novotny, Manfred P. Wirth, Michael Froehner's letter to the editor re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163. Roghmann F; May M; Aziz A Eur Urol; 2014 Jul; 66(1):e14. PubMed ID: 24598014 [No Abstract] [Full Text] [Related]
7. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198 [TBL] [Abstract][Full Text] [Related]
8. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. Mayr R; May M; Martini T; Lodde M; Pycha A; Comploj E; Wieland WF; Denzinger S; Otto W; Burger M; Fritsche HM BJU Int; 2012 Sep; 110(6 Pt B):E222-7. PubMed ID: 22314129 [TBL] [Abstract][Full Text] [Related]
9. Re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11. Taguchi S; Nakagawa T; Fukuhara H Eur Urol; 2019 Aug; 76(2):e35-e36. PubMed ID: 31054784 [No Abstract] [Full Text] [Related]
10. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [TBL] [Abstract][Full Text] [Related]
11. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414 [TBL] [Abstract][Full Text] [Related]
13. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147 [TBL] [Abstract][Full Text] [Related]
14. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175 [TBL] [Abstract][Full Text] [Related]
15. Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur urol 2007;51:699-708. Cai T; Bartoletti R Eur Urol; 2007 Aug; 52(2):611-2. PubMed ID: 17400362 [No Abstract] [Full Text] [Related]
16. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11. Gschwend JE; Heck M Eur Urol; 2019 Aug; 76(2):e37. PubMed ID: 31056229 [No Abstract] [Full Text] [Related]
17. Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy. Froehner M; Novotny V; Heberling U; Rutsch L; Litz RJ; Hübler M; Koch R; Baretton GB; Wirth MP Eur Urol; 2014 Dec; 66(6):987-90. PubMed ID: 25150172 [TBL] [Abstract][Full Text] [Related]
18. Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663). Papadopoulos G; Doumas K Urology; 2011 Aug; 78(2):486-7; author reply 487-8. PubMed ID: 21820600 [No Abstract] [Full Text] [Related]
19. Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9. Papatsoris AG; Mitsogiannis I; Deliveliotis C Eur Urol; 2010 Aug; 58(2):e19. PubMed ID: 20004053 [No Abstract] [Full Text] [Related]
20. [Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer]. Mayr R; Pycha A Aktuelle Urol; 2015 May; 46(3):236-41. PubMed ID: 26077308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]